• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌:风险评估、筛查和一级预防。

Breast Cancer: Risk Assessment, Screening, and Primary Prevention.

机构信息

Department of Medicine, University of Chicago, 5841 South Maryland Avenue, MC 3051, Chicago, IL 60637, USA.

Department of Medicine, University of Chicago, 5841 South Maryland Avenue, MC 3051, Chicago, IL 60637, USA.

出版信息

Med Clin North Am. 2023 Mar;107(2):271-284. doi: 10.1016/j.mcna.2022.10.007.

DOI:10.1016/j.mcna.2022.10.007
PMID:36759097
Abstract

This review provides an outline of a risk-based approach to breast cancer screening and prevention. All women should be assessed for breast cancer risk starting at age 18 with identification of modifiable and non-modifiable risk factors. Patients can then be stratified into average, moderate, and high-risk groups with personalized screening and prevention plans. Counseling on breast awareness and lifestyle changes is recommended for all women, regardless of risk category. High-risk individuals may benefit from additional screening modalities such as MRI and chemoprevention and should be managed closely by a multidisciplinary team.

摘要

本综述提供了一种基于风险的乳腺癌筛查和预防方法概述。所有女性应从 18 岁开始评估乳腺癌风险,确定可改变和不可改变的危险因素。然后,患者可以根据个人情况分为低危、中危和高危人群,并制定个性化的筛查和预防计划。建议所有女性进行乳房保健和生活方式改变的咨询,无论风险类别如何。高危个体可能受益于额外的筛查方式,如 MRI 和化学预防,应由多学科团队密切管理。

相似文献

1
Breast Cancer: Risk Assessment, Screening, and Primary Prevention.乳腺癌:风险评估、筛查和一级预防。
Med Clin North Am. 2023 Mar;107(2):271-284. doi: 10.1016/j.mcna.2022.10.007.
2
Breast cancer prevention.乳腺癌预防
Breast J. 2015 Jan-Feb;21(1):76-81. doi: 10.1111/tbj.12352. Epub 2014 Nov 20.
3
A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system.一种用于乳腺致密型女性的基于网络的个性化风险沟通与决策工具:综合医疗保健系统内一项随机对照试验的设计与方法
Contemp Clin Trials. 2017 May;56:25-33. doi: 10.1016/j.cct.2017.02.009. Epub 2017 Feb 28.
4
Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.BRCA 突变携带者的双侧预防性乳房切除术:外科医生需要了解的内容。
Ann Ital Chir. 2019;90:1-2.
5
Women's perceptions of the adoption of personalised risk-based breast cancer screening and primary prevention: a systematic review.女性对采用基于个体化风险的乳腺癌筛查和初级预防措施的看法:系统评价。
Acta Oncol. 2018 Oct;57(10):1275-1283. doi: 10.1080/0284186X.2018.1481291. Epub 2018 Jun 8.
6
Breast cancer genetics and risk assessment: an overview for the clinician.乳腺癌遗传学和风险评估:临床医生的概述。
Climacteric. 2023 Jun;26(3):229-234. doi: 10.1080/13697137.2023.2184254. Epub 2023 Apr 3.
7
Identifying women with increased risk of breast cancer and implementing risk-reducing strategies and supplemental imaging.识别具有乳腺癌风险增加的女性,并实施降低风险策略和补充性影像学检查。
Breast Cancer. 2022 Jan;29(1):19-29. doi: 10.1007/s12282-021-01298-x. Epub 2021 Oct 19.
8
Women's health behaviour change after receiving breast cancer risk estimates with tailored screening and prevention recommendations.女性在收到针对乳腺癌风险评估的个性化筛查和预防建议后,其健康行为发生改变。
BMC Cancer. 2022 Jan 16;22(1):69. doi: 10.1186/s12885-022-09174-3.
9
Personalized assessment and management of women at risk for breast cancer in North America.北美乳腺癌高危女性的个性化评估与管理。
Womens Health (Lond). 2015 Mar;11(2):213-23; quiz 223-4. doi: 10.2217/whe.14.79.
10
Practice Bulletin No. 179 Summary: Breast Cancer Risk Assessment and Screening in Average-Risk Women.第179号实践公告摘要:一般风险女性的乳腺癌风险评估与筛查
Obstet Gynecol. 2017 Jul;130(1):241-243. doi: 10.1097/AOG.0000000000002151.

引用本文的文献

1
Risk assessment tools for women with breast atypia: A systematic review.乳腺非典型增生女性的风险评估工具:一项系统综述。
Am J Surg. 2025 Sep 2;250:116598. doi: 10.1016/j.amjsurg.2025.116598.
2
From Variability to Standardization: The Impact of Breast Density on Background Parenchymal Enhancement in Contrast-Enhanced Mammography and the Need for a Structured Reporting System.从变异性到标准化:乳腺密度对对比增强乳腺钼靶中背景实质强化的影响以及对结构化报告系统的需求
Cancers (Basel). 2025 Jul 30;17(15):2523. doi: 10.3390/cancers17152523.
3
Regulatory Roles of miR-155-5p, miR-21-5p, miR-93-5p, and miR-140-5p in Breast Cancer Progression.
miR-155-5p、miR-21-5p、miR-93-5p和miR-140-5p在乳腺癌进展中的调控作用
Curr Issues Mol Biol. 2025 May 20;47(5):377. doi: 10.3390/cimb47050377.
4
Expression characteristics, molecular mechanisms, and clinical significance of DICER1 in breast cancer.DICER1在乳腺癌中的表达特征、分子机制及临床意义
Front Genet. 2025 Jul 1;16:1586287. doi: 10.3389/fgene.2025.1586287. eCollection 2025.
5
HCAR3 and Kynurenic Acid in Cancer: A Promising Axis of Immunometabolic Regulation or a Scientific Mirage?癌症中的HCAR3与犬尿氨酸:一条有前景的免疫代谢调控轴还是科学幻想?
Int J Mol Sci. 2025 Jun 28;26(13):6269. doi: 10.3390/ijms26136269.
6
Prevalence of presumptive clinical signs of breast cancer among women attending an early detection campaign in Lomé in 2023.2023年在洛美参加早期检测活动的女性中乳腺癌推定临床体征的患病率。
Pan Afr Med J. 2025 Apr 9;50:98. doi: 10.11604/pamj.2025.50.98.43237. eCollection 2025.
7
The diagnostic value of real-time ultrasound elastography and contrast-enhanced ultrasound in BI-RADS 4A breast lesions.实时超声弹性成像和超声造影在乳腺影像报告和数据系统(BI-RADS)4A类乳腺病变中的诊断价值
Gland Surg. 2025 Mar 31;14(3):488-497. doi: 10.21037/gs-2025-93. Epub 2025 Mar 26.
8
Expression of Fascin and DNA Topoisomerase 2-Alpha in Breast Carcinoma: Correlation with Histological Subtypes and Other Prognostic Markers.Fascin和DNA拓扑异构酶2α在乳腺癌中的表达:与组织学亚型及其他预后标志物的相关性
Int J Mol Sci. 2025 Mar 27;26(7):3076. doi: 10.3390/ijms26073076.
9
Global disease burden of breast cancer attributable to high fasting plasma glucose: a comprehensive analysis from the global burden of disease study.空腹血糖升高所致乳腺癌的全球疾病负担:来自全球疾病负担研究的综合分析
Front Endocrinol (Lausanne). 2025 Feb 13;16:1498207. doi: 10.3389/fendo.2025.1498207. eCollection 2025.
10
RNF135 promotes the stemness of breast cancer cells by ubiquitinating and degrading DDX58.RNF135通过泛素化和降解DDX58来促进乳腺癌细胞的干性。
Transl Oncol. 2025 Apr;54:102321. doi: 10.1016/j.tranon.2025.102321. Epub 2025 Feb 21.